Phytochemical CRO & CDMO Industrial Benchmark

ODM Exacting Standards Manufacturers & Suppliers

Bridging classical phytotherapy with molecular precision. High-performance active screening, validated HPLC/HPTLC analytical fingerprints, and comprehensive Phase I–IV clinical validation under rigorous global compliance frameworks.

Precision Engineering Solutions

Featured Exacting Standards Botanical R&D Suites

Direct contract research and specialized ODM development programs designed for international pharmaceutical groups and clinical-grade nutraceutical manufacturers.

Analysis Method China Establishment of analysis methods of active ingredients Supplier

Establishment of Analysis Methods of Active Ingredients

Validated HPLC, GC, and chromatographic fingerprinting to secure batch-to-batch chemical repeatability and international monograph compliance.

Explore Specifications
Bioactive Screening China Screening of the active ingredients of plants Manufacturer

Screening of the Active Ingredients of Plants

High-throughput isolation and bio-guided fractionation to pinpoint target alkaloids, polyphenols, and saponins with commercial efficiency.

Explore Specifications
Preclinical Assay OEM In Vitro Test Research Service Manufacturers

OEM In Vitro Test & Cellular Research Service

Rigorous cell-line screening, metabolic pathway assays, and receptor-binding evaluations to establish mechanism-of-action before clinical phases.

Explore Specifications
Sourcing Science ODM Study and evaluation of botanical potency

Botanical Potency Evaluation Across Origins & Seasons

Spatial-temporal metabolic profiling across diverse harvesting seasons, altitudes, and plant tissues to optimize raw ingredient procurement.

Explore Specifications
In Vivo Validation OEM Animal study Supplier

OEM In Vivo Preclinical Animal Study Service

Full toxicological dossiers including acute LD50, sub-chronic toxicity, and specialized disease animal models to support global regulatory filings.

Explore Specifications
Clinical Trials ODM Clinic study Phase1 Phase 4 Manufacturer

ODM Clinical Study Architecture (Phase I to Phase IV)

GCP-compliant human trials for functional claim substantiation, pharmacokinetic bioavailability charting, and New Drug Application (NDA) submissions.

Explore Specifications
Industrial Screening Botanical Active Screening Services

Plant Bioactive Extraction & Fractionation Protocol

Proprietary multi-stage extraction and column separation workflows designed to produce active pharmaceutical ingredients (APIs) at commercial scale.

Explore Specifications
Validation Monograph Analytical Method Establishing Services

Botanical Quality Monograph & Assay Standardization

Developing orthogonal testing protocols to eliminate adulteration, measure degradation pathways, and meet pharmacopeial standards worldwide.

Explore Specifications
Macro-Industrial Solutions

The Paradigm Shift Toward Exacting Standards in Botanical Manufacturing

Overcoming natural chemical heterogeneity through synchronized contract research, molecular fingerprinting, and standardized CDMO process engineering.

Resolving Batch-to-Batch Phytochemical Variance

Unlike synthetic single-molecule synthesis, botanical matrices are fundamentally heterogeneous. Soil microbiome composition, seasonal rainfall variations, and thermal stress introduce significant shifts in active secondary metabolites. MedGence’s Exacting Standards deploy multi-dimensional chromatographic profiling (HPTLC, HPLC-DAD, and GC-MS) across all raw materials.

By determining the critical harvest window and geo-climatic origin across nearly 400 single-herb monographs, our ODM pipeline transforms unpredictable natural harvests into chemically defined, reproducible therapeutic raw materials.

Modernizing Classical Formulas into Global Therapeutics

Traditional Chinese Medicine (TCM) contains millennia of empirical safety and multi-target efficacy data. However, international regulatory adoption is hindered by the lack of clear mechanism elucidation and modern pharmacokinetics.

Having completed modern pharmaceutical research on 83 classic TCM formulas and registered 56 hospital preparations, we engineer exact extraction fractions that retain synergistic medicinal interactions while purifying out inert polysaccharides, heavy metal contaminants, and toxic alkaloids.

Seamless CRO-to-CDMO Transition

The traditional pharmaceutical development model is fragmented: academic labs execute basic screening, contract research organizations run animal trials, and third-party toll manufacturers attempt mass production. This fragmentation results in loss of know-how and formulation failures during pilot scale-up.

MedGence bridges this gap with an end-to-end infrastructure. Our technical leadership directly supervises our dedicated pilot plants and collaborative cGMP facilities, ensuring validated benchtop extraction parameters translate seamlessly into metric-ton commercial runs.

Global Landscape & Benchmarks

Contract Manufacturing vs. Exacting Standards ODM Architecture

International commercial buyers now operate under heightened scrutiny from the FDA, EMA, TGA, and NMPA. Compare conventional toll contract extractors with MedGence’s integrated scientific CDMO model.

Evaluation Parameter Commodity Contract Extractors (OEM) MedGence Exacting Standards ODM / CDMO Strategic Industry Benefit
Raw Material Sourcing Commodity spot-market sourcing; unmonitored seasonality; high batch variance. Multi-region geo-climatic potency mapping; optimized chronobiological harvesting. Maximum Yield & Potency
Analytical Verification Basic TLC testing, UV-Vis spectrophotometry prone to matrix interference. Orthogonal HPLC-DAD-MS, GC-MS/MS, HPTLC fingerprinting, heavy metal ICP-MS. Audit-Proof Monograph
Efficacy Substantiation Relies on third-party public literature; no proprietary bio-assays conducted. In vitro receptor assays, target cell lines, and GLP-standard in vivo animal models. Proprietary IP Protection
Clinical Translation None; client bears complete burden and liability of clinical trial design. Phase I–IV clinical study architecture, ethics board management, and trial reporting. Turnkey Drug Registration
Scalability & Delivery Fixed toll-processing lines with high minimum orders and limited dosage formats. Flexible pilot-to-bulk suites: liquids, capsules, softgels, granules, volatile oils. Rapid Time-to-Market
14+
Years of Natural Medicine R&D Experience
300+
Full-Time Research Scientists & Analytical Chemists
83
Classic TCM Formulas Modernized with Full Dossiers
~400
Single-Herb Standards & Extraction Protocols Established
Technical Operational Roadmap

The Six Pillars of Exacting Standards Methodology

From raw botanical harvest to commercial dosage formulation, every stage of our ODM process is subject to quantitative scientific controls.

1. Chronobiological & Geo-Origin Potency Mapping

Botanical potency is governed by abiotic variables. Our botanical scientists evaluate secondary metabolite concentrations across diverse regions, altitudinal zones, and plant parts (rhizomes, leaves, fruits, bark). We determine exact harvest windows to lock in peak bioactive densities.

  • Geo-authentic botanical authentication
  • Seasonal active metabolite curves
  • Sustainable procurement protocols

2. High-Resolution Fingerprint & Assay Development

We engineer precision analytical monographs utilizing High-Performance Liquid Chromatography (HPLC), High-Performance Thin-Layer Chromatography (HPTLC), Gas Chromatography (GC), and mass spectrometry to identify markers and ensure no chemical drift between manufacturing batches.

  • Chromatographic fingerprint correlation
  • Trace pesticide & residual solvent limits
  • Heavy metal testing via ICP-MS

3. Industrial Critical Process Parameters (CPP)

Lab extraction frequently collapses at pilot scale due to heat sensitivity or improper solvents. Our process engineers systematically optimize extraction temperature, fluid dynamics, membrane filtration, macroporous resin adsorption, and low-temperature spray drying.

  • Pilot-scale process parameter definition
  • Thermal degradation prevention kinetics
  • High-efficiency solvent recovery

4. Preclinical Safety & In Vitro Pharmacology

Before commercial formulation, every natural compound or formulation candidate undergoes comprehensive safety dossiers: median lethal dose (LD50), acute toxicity, sub-chronic toxicity, Ames bacterial reverse mutation tests, and target cellular signaling evaluations.

  • OECD-compliant toxicology profiling
  • Cellular mechanistic assays (in vitro)
  • Preclinical rodent efficacy models

5. Clinical Trial Protocols & Regulatory Submissions

For dietary supplements requiring structure-function claims or innovative natural drugs requiring NDA approval, we design and supervise human clinical trials. Leveraging relationships with top teaching hospitals, we conduct Phase I through Phase IV studies.

  • Double-blind randomized clinical trials
  • Pharmacokinetic (PK/PD) profiling
  • IRB ethics board submission dossiers

6. Advanced Finished Dosage Delivery Engineering

Bioactive integrity can be compromised during dosage manufacturing. Our formulation scientists solve bioavailability, dispersion, and palatability challenges, providing stable finished products across a wide spectrum of customer delivery formats.

  • Oral liquids, ampoules, and concentrates
  • Enteric capsules, softgels, and micro-tablets
  • High-solubility powders and stable granules
Compliance & IP Protection

Localized Support & Cross-Border Compliance Infrastructure

Eliminating market entry barriers across North America, Europe, and Asia-Pacific through harmonized quality standard dossiers and ironclad intellectual property security.

Multi-Jurisdictional Regulatory Alignment

Navigating the intersection between food supplements, natural health products, and pharmaceutical botanical drugs requires rigorous regulatory documentation. MedGence produces Common Technical Document (CTD) Module 3 (Quality/CMC) files designed for direct submission to:

  • United States FDA: 21 CFR Part 111 (Dietary Supplements) & Part 312/314 (Botanical Drug Guidance for IND/NDA).
  • European Union (EMA): Traditional Herbal Medicinal Products Directive (THMPD 2004/24/EC) and Well-Established Use monographs.
  • Health Canada & Australia TGA: Natural Health Product (NHP) licensing and Therapeutic Goods listed medicine registers.
  • China NMPA: Hospital Preparation Classifications and Class 1.1/2.3 Innovative Traditional Botanical Drugs.

Strict Confidentiality & IP Fortification

Commercial competitive advantage depends on the inviolable security of proprietary formulas, unique extraction parameters, and screening results. Under our entrusted contract research and manufacturing model:

  • Comprehensive Bilateral Non-Disclosure Agreements (NDAs): Covering all biological targets, chemical pathways, and formulation ratios.
  • Isolated Cleanroom Pilot Runs: Dedicated processing suites preventing cross-contamination and unauthorized formula observation.
  • Air-Gapped Data Retention: Analytical method validation data, spectra, and trial registries stored on secure, encrypted client-dedicated databases.
  • Clear IP Ownership: All custom analytical methods and improved extraction processes generated under contract are fully transferred to the client.
Applied Field Scenarios

Specialized Applications Across Key Therapeutic Markets

Real-world execution showing how our exact ODM capabilities translate across commercial sectors.

Cardiovascular & Metabolic Modernization

Context: A multinational pharmaceutical brand required a standardized botanical extract targeting endothelial health and metabolic syndrome.

Execution: We screened 14 harvesting regions, developed an orthogonal HPLC method for three key active flavonoids, isolated them using countercurrent chromatography, completed an in vivo rodent hypertension model, and transferred the process into 500kg commercial batch manufacturing.

HPLC Fingerprinting In Vivo Model Pilot-to-Bulk

High-Efficacy Dermocosmetic Actives

Context: A premium skincare conglomerate sought a patented natural polyphenol complex with documented anti-inflammatory and cellular repair capabilities.

Execution: Conducted in vitro human keratinocyte (HaCaT) UV-induced oxidation models, established LD50 and patch-test dermal irritation records, engineered a subcritical solvent extraction yielding 98% purity, and formulated a clear, oxidation-resistant concentrated liquid active.

HaCaT Cell Assays Subcritical Fluid Clean Beauty IP

Hospital Preparation Industrial Scale-up

Context: A provincial TCM hospital needed to transition a historically proven clinical formula into an officially registered, industrialized hospital preparation.

Execution: Formulated comprehensive single-herb quality monographs, solved bitter taste and sedimentation in an oral liquid formulation, completed acute toxicity studies, and drafted the complete NMPA registration dossier, securing official hospital preparation approval.

56 Registrations NMPA Dossier Taste-Masking
Future-Proof Science

Technological Roadmap: The Next Decade of Phytochemical CDMO

Integrating computational cheminformatics, real-time Process Analytical Technology (PAT), and continuous automated flow extraction.

AI-Cheminformatics & In Silico Target Prediction

By 2026, MedGence is integrating machine-learning molecular docking models with our database of hundreds of thousands of research batches. This enables predictive identification of botanical compounds capable of binding complex disease targets prior to running wet-lab bioassays.

Continuous Flow Processing & PAT Monitoring

Transitioning conventional batch vessel extraction into enclosed, continuous micro-reactor and countercurrent extraction lines. Online near-infrared (NIR) and ultra-HPLC PAT sensors monitor active compound concentrations in real time, automatically adjusting solvent flow and temperature.

Synthetic Biology & Bio-Fermentation Synergy

Developing hybrid manufacturing platforms combining wild-plant extraction with enzymatic biotransformation and precision yeast fermentation, securing rare botanical glycosides and saponins that occur in trace quantities in nature without over-harvesting wild resources.

Institutional Authority

Trusted by Over 100 Leading Pharmaceutical Groups & Hospitals

Our rigorous analytical and contract manufacturing methodologies are validated by ongoing collaborations with national healthcare leaders and academic medical centers.

China Beijing Tongrentang GroupTongrentang Group
China Resources SanjiuCR Sanjiu
Sunflower Pharmaceutical GroupSunflower Pharma
Livzon Pharmaceutical GroupLivzon Pharma
Dihon Pharmaceutical GroupDihon Pharma
Golden Throat HoldingsGolden Throat
Yangtzi River PharmaceuticalYangtzi River Pharma
Beihai Gofar Chuanshan BiologicalGofar Chuanshan
Humanwell HealthcareHumanwell Group
SCIMYTH PharmaceuticalSCIMYTH Pharma
Shandong Hanfang PharmaceuticalHanfang Pharma
Luoxin Pharmaceutical GroupLuoxin Pharma
Guangdong Zhongsheng PharmaceuticalZhongsheng Pharma
Hunan Brilliance & Abundance ScientificBrilliance & Abundance
Apeloa PharmaceuticalApeloa Pharma
Hunan Heng Chang PharmaceuticalHeng Chang Pharma
Baotou Traditional Chinese MedicineBaotou TCM
Kamp MedicineKamp Medicine
Guangxi Santo PharmaceuticalSanto Pharma
Hunan Kangshou PharmaceuticalKangshou Pharma
Jiangxi Juwang PharmaceuticalJuwang Pharma
Beijing Tcmages PharmaceuticalTcmages Pharma
Guizhou Ruihe PharmaceuticalRuihe Pharma
Anhui CR Jinchan PharmaceuticalCR Jinchan
Kangmei PharmaceuticalKangmei Pharma
Hunan Tianjicaotang PharmaceuticalTianjicaotang
Jiangxi Kingstone Unite PharmaceuticalKingstone Unite
Shuguang Hospital Affiliated to Shanghai TCM UniversityShuguang Hospital
Hunan Directly Affiliated TCM HospitalHunan TCM Hospital
First Hospital of Hunan TCM University1st Hosp Hunan TCM
Second Xiangya Hospital CSUSecond Xiangya CSU
Second Hospital of Hunan TCM University2nd Hosp Hunan TCM
Orthopedics of TCM Zhuzhou CityZhuzhou Orthopedics
Technical & Commercial FAQ

Frequently Asked Questions from Global Procurement & R&D Heads

Clear answers addressing technical scope, regulatory submissions, technology transfers, and intellectual property safety.

What distinguishes an Exacting Standards ODM partner from a standard toll contract manufacturer?
A conventional contract manufacturer simply processes client-provided botanicals using fixed machinery, offering zero scientific insight if the final active potency degrades or fails specification. MedGence acts as an integrated CRO/CDMO: we perform front-end botanical screening, optimize chronobiological sourcing, establish validated chromatographic analytical methods, run in vitro/in vivo pharmacological validation, and oversee pilot-to-commercial cGMP production under strict non-disclosure.
Can MedGence handle both active ingredient extraction and finished consumer dosage forms?
Yes. Active ingredients can be supplied as concentrated liquids, spray-dried or freeze-dried extract powders, standardized pastes, and supercritical volatile oils. For finished formulations, our CDMO lines produce oral liquids, capsules, softgels, micro-tablets, soluble powders, and effervescent granules with complete primary and secondary packaging.
Which specific analytical techniques are used to validate chemical consistency across batches?
Depending on the target botanical matrix, we apply High-Performance Liquid Chromatography coupled with Diode Array and Mass Spectrometry (HPLC-DAD-MS), High-Performance Thin-Layer Chromatography (HPTLC) fingerprinting, Gas Chromatography-Flame Ionization Detection/Mass Spectrometry (GC-FID/MS), Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metal profiling, and orthogonal biological response assays.
How does MedGence support New Drug Applications (NDA) and clinical efficacy dossiers?
We manage the entire preclinical and clinical continuum. This includes OECD GLP-compliant toxicological studies (LD50, acute, sub-chronic, Ames testing), pharmacokinetic (PK/PD) profiling in animal models, and Phase I, II, III, and IV clinical studies executed in partnership with accredited teaching hospitals and Institutional Review Boards (IRBs).
How are proprietary formulas and extraction know-how protected under Chinese and international law?
All work is performed under legally binding bilateral Non-Disclosure and IP Assignment Agreements. Formulation data is segmented within air-gapped laboratory systems, physical production is isolated in private cleanroom suites, and all newly developed analytical methods or process patents generated during the project are legally assigned to the client upon contract completion.
Can you modernize traditional multi-herb formulations without losing synergistic therapeutic efficacy?
Yes. With over 83 classical TCM formulas successfully modernized, we utilize bio-guided fractionation. We separate and recombine active fractions to remove inactive fiber, sugar, and trace heavy metals, preserving the synergistic interactions of multi-herb recipes while producing a concentrated, clear, and chemically quantifiable therapeutic entity.
Turnkey Commercial Production

Contract Research & Commercial ODM Service Directory

Select a specialized development module or engage our comprehensive end-to-end CDMO pipeline for rapid international deployment.

Method Standardization China Establishment of analysis methods of active ingredients Supplier

Analytical Method Establishment & Monograph Creation

Complete chromatographic development, method validation parameters (ICH Q2), and transfer documentation for global regulatory filings.

Request Catalog & Specs
Bioactive Discovery Screening of the active ingredients of plants

Phytochemical Screening & Active Target Identification

Isolating target botanical fractions, identifying lead molecular candidates, and designing cost-effective industrial extraction routes.

Request Catalog & Specs
Cellular Assays OEM In Vitro Test Research Service

In Vitro Cellular Efficacy & Mechanism Elucidation

Primary cell cultures and organoid models to prove active antioxidant, metabolic, and anti-inflammatory pathways with quantifiable data.

Request Catalog & Specs
Sourcing Mapping Botanical potency evaluation across seasons and origins

Botanical Origin & Seasonality Potency Optimization

Evaluating geospatial metabolite concentrations across varied regions to establish an unshakeable, high-potency raw ingredient supply chain.

Request Catalog & Specs
Toxicology & Safety OEM Animal study Supplier

Preclinical Rodent Pharmacokinetics & Safety Dossiers

Full animal bio-distribution, dose-ranging, chronic toxicity, and pharmacodynamics reports required for regulatory clearance.

Request Catalog & Specs
Human Clinical Trials ODM Clinic study Phase1 to Phase 4

GCP Clinical Trial Execution (Phase I–IV)

Hospital-partnered clinical trial administration for functional supplement claim verification and drug dossier submissions.

Request Catalog & Specs
Custom Fractionation Botanical Active Screening Services

Target Bioactive Extraction & Purification Lines

Pilot-to-commercial scale purification utilizing macroporous adsorption, countercurrent chromatography, and low-temperature drying.

Request Catalog & Specs
Monograph Creation Analytical Method Establishing Services

International Quality Monograph Standardization

Comprehensive pharmacopeial alignment (USP, EP, CP) establishing chemical reference standards and precise degradation profiles.

Request Catalog & Specs